Search
for

    GlossaryPemphigoid Gestationis

    rare autoimmune blistering disorder occurring during pregnancy

    Pemphigoid Gestationis, also known as Herpes Gestationis, is a rare autoimmune blistering disorder that occurs during pregnancy. It is characterized by an itchy rash that typically starts around the belly button and can spread to other parts of the body. The condition is caused by the immune system mistakenly attacking the skin, leading to blister formation. It usually resolves after childbirth but may require medical treatment to manage symptoms.

    Related Terms

    Research

    5 / 616 results
      Skin Diseases in Pregnancy

      research Skin disease in pregnancy

      34 citations , June 2014 in “The BMJ”
      Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.
      Dermatoses of Pregnancy

      research Dermatoses of pregnancy

      33 citations , August 2006 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.
      Skin Disease in Pregnancy

      research Skin disease in pregnancy

      24 citations , March 2015 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

    Community Join

    5 / 1000+ results

      community Setipiprant/PGE2 feedbacks?

      in Question  4 upvotes 7 years ago
      The conversation discusses using PGE2 as a hair growth stimulant, comparing it to minoxidil, and considering the addition of Setipiprant. Concerns about side effects like skin damage and cost are also mentioned.

      community Best Treatment In The Pipeline?

      in Chat  15 upvotes 1 year ago
      New treatments for AGA are emerging, including pyrilutumide, gt0029, scube3, kx-826, and pp405. Verteporfin is mentioned as a promising option.

      community Pelage are starting phase 3 for PP405 towards the end of 2026

      in Chat  180 upvotes 1 month ago
      PP405 is moving to late-stage trials, showing potential for hair regrowth, with 31% of male patients experiencing a 20% increase in hair density. Veradermics is developing an oral minoxidil version, and there is interest in combining treatments for better results.

      community DLQ01: A Better "Minoxidil" PGF2a synthetic analogue.

      in Research/Science  3 upvotes 1 year ago
      DLQ01, a prostaglandin F2α analog, shows promise for hair growth by directly stimulating PGE2/PGF receptors without needing conversion, and can be combined with minoxidil and retinoids like tretinoin for enhanced effectiveness. Minoxidil's efficacy may be reduced by COX-1 inhibitors, but using prostaglandin analogs like Latanoprost or Bimatoprost can help maintain its effectiveness.